{"disease":{"id":"chemotherapy-induced-nausea-and-vomiting","name":"Chemotherapy-induced nausea and vomiting","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":17,"pipeline_drug_count":0,"trial_count":1},"drugs":{"marketed":[{"drug_id":"metaclopramide","indication_name":"Chemotherapy-induced nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Metaclopramide","company_name":"Institute of Liver and Biliary Sciences, India","drug_phase":"discontinued","molecular_target":"Aldehyde oxidase, Myeloperoxidase, Solute carrier family 22 member 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"netupitant","indication_name":"Chemotherapy-induced nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Akynzeo","generic_name":"NETUPITANT","company_name":"Helsinn Hlthcare","drug_phase":"marketed","molecular_target":"Substance-P receptor","drug_class":"Serotonin-3 Receptor Antagonist [EPC]","quality_score":57,"revenue":null,"mechanism":"Akynzeo works by blocking the substance P/neurokinin-1 receptor to prevent nausea and vomiting caused by chemotherapy."},{"drug_id":"aprepitant","indication_name":"Chemotherapy-induced nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Emend","generic_name":"APREPITANT","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Substance-P receptor","drug_class":"Substance P/Neurokinin-1 Receptor Antagonist [EPC]","quality_score":62,"revenue":null,"mechanism":"Emend works by blocking the action of a natural substance called substance P, which is involved in the vomiting reflex."},{"drug_id":"metoclopramide","indication_name":"Chemotherapy-induced nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Reglan","generic_name":"METOCLOPRAMIDE","company_name":"Hikma","drug_phase":"marketed","molecular_target":"D(3) dopamine receptor","drug_class":"Dopamine-2 Receptor Antagonist","quality_score":57,"revenue":null,"mechanism":""},{"drug_id":"metoclopramide-hydrochloride","indication_name":"Chemotherapy-induced nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Reglan","generic_name":"Metoclopramide Hydrochloride","company_name":"Hikma","drug_phase":"marketed","molecular_target":"Acetylcholine receptor sensitization; dopamine antagonism (implied)","drug_class":"Prokinetic agent","quality_score":10,"revenue":null,"mechanism":"Metoclopramide stimulates upper GI tract motility by sensitizing tissues to acetylcholine action."},{"drug_id":"fosnetupitant","indication_name":"Chemotherapy-induced nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Akynzeo","generic_name":"FOSNETUPITANT","company_name":"Helsinn Hlthcare","drug_phase":"marketed","molecular_target":"Substance-P receptor","drug_class":"Serotonin-3 Receptor Antagonist [EPC]","quality_score":48,"revenue":null,"mechanism":"Akynzeo works by blocking the action of substance-P, a natural substance in the body that triggers nausea and vomiting."},{"drug_id":"tropisetron","indication_name":"Chemotherapy-induced nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Navoban","generic_name":"TROPISETRON","company_name":"","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A","drug_class":"tropisetron","quality_score":26,"revenue":null,"mechanism":""},{"drug_id":"marinol","indication_name":"Chemotherapy-induced nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Marinol","company_name":"Jazz Pharmaceuticals","drug_phase":"marketed","molecular_target":"N-arachidonyl glycine receptor, Cannabinoid receptor 2, Fatty-acid amide hydrolase 1","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"estrone","indication_name":"Chemotherapy-induced nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Estron","generic_name":"ESTRONE","company_name":"Watson Labs","drug_phase":"marketed","molecular_target":"Estrogen receptor","drug_class":"estrone","quality_score":29,"revenue":null,"mechanism":""},{"drug_id":"gran","indication_name":"Chemotherapy-induced nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"GRAN®","company_name":"EVIVE Biotechnology","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3B, Multidrug and toxin extrusion protein 1, Solute carrier family 22 member 2","drug_class":"","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"nabilone","indication_name":"Chemotherapy-induced nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cesamet","generic_name":"NABILONE","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Cannabinoid receptor 1","drug_class":"Cannabinoid [EPC]","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"fosaprepitant","indication_name":"Chemotherapy-induced nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Emend","generic_name":"FOSAPREPITANT","company_name":"","drug_phase":"marketed","molecular_target":"Substance-P receptor","drug_class":"Substance P/Neurokinin-1 Receptor Antagonist","quality_score":75,"revenue":null,"mechanism":"Emend blocks the action of substance P, a natural substance that can trigger nausea and vomiting."},{"drug_id":"rolapitant","indication_name":"Chemotherapy-induced nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Varubi","generic_name":"ROLAPITANT","company_name":"Tersera","drug_phase":"marketed","molecular_target":"Substance-P receptor","drug_class":"Substance P/Neurokinin-1 Receptor Antagonist","quality_score":65,"revenue":null,"mechanism":"Varubi works by blocking the substance-P receptor, a key player in the body's response to chemotherapy-induced nausea and vomiting."},{"drug_id":"dronabinol","indication_name":"Chemotherapy-induced nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Marinol","generic_name":"DRONABINOL","company_name":"Wellhouse Pharma","drug_phase":"marketed","molecular_target":"Cannabinoid receptors","drug_class":"Cannabinoid [EPC]","quality_score":80,"revenue":null,"mechanism":"Dronabinol acts on cannabinoid receptors in the CNS, potentially through central sympathomimetic activity."},{"drug_id":"cesamet","indication_name":"Chemotherapy-induced nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cesamet","company_name":"Veeda Oncology","drug_phase":"marketed","molecular_target":"Cannabinoid receptor 2, Cannabinoid receptor 1, Cannabinoid receptor 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"tetrahydrocannabinol","indication_name":"Chemotherapy-induced nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"tetrahydrocannabinol","company_name":"Wageningen University","drug_phase":"marketed","molecular_target":"N-arachidonyl glycine receptor, Cannabinoid receptor 2, Fatty-acid amide hydrolase 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"ondansetron","indication_name":"Chemotherapy-induced nausea and vomiting","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zofran","generic_name":"ondansetron","company_name":"GSK (originally Glaxo)","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, 5-hydroxytryptamine receptor 3B, Multidrug and toxin extrusion protein 1","drug_class":"5-HT3 receptor antagonist (antiemetic)","quality_score":null,"revenue":null,"mechanism":"Selective 5-HT3 receptor antagonist that blocks serotonin-mediated nausea and vomiting signals in the CTZ and vagal afferents."}],"pipeline":[],"offLabel":[],"totalMarketed":17,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06886451","title":"Vomiting Prevention in Children With Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":1332,"lead_sponsor_name":"The Hospital for Sick Children","has_results":false},{"nct_id":"NCT01594749","title":"Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-Induced Nausea and Vomiting (MK-0517-031)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1015,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT03740672","title":"Adherence to the Antiemesis National Comprehensive Cancer Network (NCCN) Guideline","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT03601871","title":"The Efficacy and Safety of Thalidomide in Preventing CINV Induced by Cisplatin-containing Chemotherapy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":880,"lead_sponsor_name":"Yunpeng Liu","has_results":false},{"nct_id":"NCT00337727","title":"Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV)(0869-130)(COMPLETED)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":848,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT07081256","title":"To Evaluate the Efficacy and Safety of QLM2010 for Prevention of Chemotherapy-induced Nausea and Vomiting After Highly Emetogenic Chemotherapy.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":665,"lead_sponsor_name":"Qilu Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT06331520","title":"NEPA Combined With Olanzapine, Dexamethasone-sparing for the Effect of CINV in Patients Receiving HEC Regimens","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":644,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT05838638","title":"Serious Gaming for Chemotherapy-induced Nausea and Vomiting","phase":"NA","overall_status":"RECRUITING","enrollment_count":610,"lead_sponsor_name":"University of Central Florida","has_results":false},{"nct_id":"NCT04437017","title":"Olanzapine or Dexamethasone, With 5-HT3 RA and NK-1 RA, to Prevent CINV","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":557,"lead_sponsor_name":"Fifth Affiliated Hospital, Sun Yat-Sen University","has_results":false},{"nct_id":"NCT06756022","title":"Dolasetron for the Prevention of CINV in Children With Acute Lymphoblastic Leukemia","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Anhui Provincial Children's Hospital","has_results":false},{"nct_id":"NCT05242874","title":"Anti-emetic Prophylaxis With or Without Dexamethasone","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":442,"lead_sponsor_name":"Henan Cancer Hospital","has_results":false},{"nct_id":"NCT00952341","title":"Aprepitant/MK0869 for Prevention of Chemotherapy Induced Nausea and Vomiting Associated With Cisplatin (0869-169)(COMPLETED)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":421,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT04817189","title":"Oral Akynzeo® vs Standard of Care in Preventing CINV in High-risk MEC Patients (MyRisk)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":414,"lead_sponsor_name":"Helsinn Healthcare SA","has_results":true},{"nct_id":"NCT03403712","title":"A Study to Assess the Safety and the Efficacy of IV Fosnetupitant/Palonosetron (260 mg/0.25 mg) Combination Compared to Oral Netupitant/Palonosetron (300 mg/0.5 mg) Combination for the Prevention of CINV in AC Chemotherapy in Women With Breast Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":404,"lead_sponsor_name":"Helsinn Healthcare SA","has_results":true},{"nct_id":"NCT02909478","title":"Aprepitant Without Steroid in Preventing Chemotherapy-induced Nausea and Vomiting in Patients With Colorectal Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":315,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT01362530","title":"A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":307,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT05805800","title":"Olanzapine and 5-HT3 With or Without Dexamethasone to Prevent CINV","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":275,"lead_sponsor_name":"Xingchen Peng","has_results":false},{"nct_id":"NCT03674294","title":"Aprepitant Triple Therapy for the Prevention of CINV in Nondrinking and Young Women Who Received Moderately Emetogenic Chemotherapy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":248,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT01697579","title":"Study of the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Children (MK-0517-029)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":240,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT03219710","title":"\"Olanzapine for Prevention of Chemotherapy Induced Nausea and Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy (HEC)\"","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":240,"lead_sponsor_name":"All India Institute of Medical Sciences","has_results":false},{"nct_id":"NCT03061396","title":"The Comparative Study on the Efficacy and Safety of Single Acupoint and Matching Acupoints","phase":"NA","overall_status":"UNKNOWN","enrollment_count":208,"lead_sponsor_name":"Tianjin University of Traditional Chinese Medicine","has_results":false},{"nct_id":"NCT03649230","title":"Observational Study on the Use of Akynzeo® in Patients Receiving HEC","phase":"","overall_status":"COMPLETED","enrollment_count":207,"lead_sponsor_name":"Purdue Pharma, Canada","has_results":true},{"nct_id":"NCT07482891","title":"An Exploratory Study on Efficacy and Safety of Fosaprepitant and Palonosetron Hydrochloride for Injection in Preventing CINV From Multi-Agent HEC","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Shanghai 6th People's Hospital","has_results":false},{"nct_id":"NCT03232541","title":"The Effects of Acupuncture and the Therapist´s Communication on Chemotherapy Induced Nausea and Vomiting","phase":"NA","overall_status":"COMPLETED","enrollment_count":198,"lead_sponsor_name":"Västernorrland County Council, Sweden","has_results":false},{"nct_id":"NCT04342780","title":"Prevalence of Delayed Chemotherapy Associated Nausea","phase":"","overall_status":"COMPLETED","enrollment_count":172,"lead_sponsor_name":"Antje Koller","has_results":false},{"nct_id":"NCT04918069","title":"Capsaicin to Prevent Delayed Chemotherapy Induced Nausea and Vomiting (CapCIN)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":160,"lead_sponsor_name":"Christian Medical College, Vellore, India","has_results":false},{"nct_id":"NCT03948477","title":"Pantoprazole Prophylaxis Against Delayed CINV for Patients Receiving Breast Cancer Chemotherapy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":160,"lead_sponsor_name":"University of Auckland, New Zealand","has_results":false},{"nct_id":"NCT03571126","title":"Olanzapine for the Prevention and Treatment of Nausea and Vomiting Induced by Chemotherapy of Lung Cancer","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":156,"lead_sponsor_name":"Zunyi Medical College","has_results":false},{"nct_id":"NCT03862144","title":"NEPA to Prevent Chemotherapy Induced Nausea and Vomiting in Patients With Breast Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Consorzio Oncotech","has_results":false},{"nct_id":"NCT04912271","title":"Granisetron Transdermal Patch for Prophylaxis of Delayed CINV","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":140,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT06850454","title":"Olanzapine Versus Placebo for Moderately Emetogenic Chemotherapy","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":140,"lead_sponsor_name":"Mahidol University","has_results":false},{"nct_id":"NCT03478605","title":"Trial to Evaluate Efficacy of Olanzapine With Short-acting 5HT3 Inhibitors in Chemotherapy-induced Nausea & Vomiting (CINV) Prophylaxis","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":130,"lead_sponsor_name":"Blokhin's Russian Cancer Research Center","has_results":false},{"nct_id":"NCT04430361","title":"the Efficacy and Safety of 5-HT3 Receptor Antagonist, Dexamethasone or Megestrol Acetate Dispersible Tablets in the Control of Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Henan Cancer Hospital","has_results":false},{"nct_id":"NCT05230654","title":"Efficacy and Safety of Fosaprepitant in Preventing Chemotherapy-induced Vomiting in Children Treated With Medium and High Emetic Chemotherapeutic Drugs","phase":"NA","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Shanghai Children's Medical Center","has_results":false},{"nct_id":"NCT04873284","title":"Comparative Study of Fosaprepitant and Aprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting in Pediatric Caner Patients","phase":"NA","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Shanghai Children's Medical Center","has_results":false},{"nct_id":"NCT05564286","title":"Triple Antiemetic Regimen for Chemoradiotherapy in Cervical Cancer or Nasopharyngeal Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":116,"lead_sponsor_name":"Shantou University Medical College","has_results":false},{"nct_id":"NCT03984214","title":"Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":109,"lead_sponsor_name":"Arbeitsgemeinschaft medikamentoese Tumortherapie","has_results":false},{"nct_id":"NCT06950632","title":"This Study Will Investigate the Effectiveness of Peppermint Oil Inhalation in Reducing the Intensity and Frequency of Acute Nausea and Vomiting Among Cancer Patients Undergoing Chemotherapy. Chemotherapy-induced Nausea and Vomiting (CINV) Are Among the Most Distressing Side Effects Experienced by pa","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":106,"lead_sponsor_name":"University of Health Sciences Lahore","has_results":false},{"nct_id":"NCT04054193","title":"Safety of a Three-Day Fosaprepitant Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-045)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":103,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT06065722","title":"Prevention of Breakthrough CINV in Patients Receiving Moderately or Highly Emetogenic Chemotherapy","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Simon Williamson Clinic","has_results":false},{"nct_id":"NCT06017284","title":"Thalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic Cancer","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT05319860","title":"Aromatherapy for Chemotherapy-induced Nausea and Vomiting (CINV)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"University of Miami","has_results":true},{"nct_id":"NCT00818259","title":"A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134)","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":92,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT05251337","title":"Use of Aromatherapy to Reduce Symptom Burden","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":92,"lead_sponsor_name":"Indiana University","has_results":true},{"nct_id":"NCT05792228","title":"A Standardized Intervention to Improve the Management of Chemotherapy-induced Nausea and Vomiting","phase":"NA","overall_status":"COMPLETED","enrollment_count":92,"lead_sponsor_name":"Tianjin Medical University Cancer Institute and Hospital","has_results":false},{"nct_id":"NCT04535141","title":"Olanzapine for Nausea/Vomiting Prophylaxis in Recipients of Hematopoietic Stem Cell Transplants","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":91,"lead_sponsor_name":"UNC Lineberger Comprehensive Cancer Center","has_results":true},{"nct_id":"NCT07292831","title":"Geranium Inhalation Aromatherapy for Reducing Nausea and Vomiting in Cancer Patients Undergoing Chemotherapy","phase":"NA","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Universitas Muhammadiyah Surakarta","has_results":false},{"nct_id":"NCT04232423","title":"Olanzapine for Chemotherapy-induced Nausea and Vomiting Prophylaxis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Department of Medical Services Ministry of Public Health of Thailand","has_results":false},{"nct_id":"NCT07581119","title":"Effect of Mandala Coloring on Nausea, Fatigue, and Well-Being in Chemotherapy Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":85,"lead_sponsor_name":"University of Gaziantep","has_results":false},{"nct_id":"NCT03143829","title":"Promoting Cancer Symptom Management in Older Adults","phase":"NA","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"University of Central Florida","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}